Embryo transfer is the final and most delicate stage of the IVF process. After weeks of ovarian stimulation, egg retrieval, fertilization in the laboratory, and careful embryo culture, the moment of transfer represents the culmination of your fertility journey thus far. Understanding exactly what to expect—before, during, and after the procedure—can significantly reduce anxiety and help you prepare both physically and emotionally for this pivotal step toward parenthood.
{IMG1}
Embryo transfer is a minimally invasive procedure in which one or more carefully selected embryos are placed into the uterus using a thin, flexible catheter. The goal is for at least one embryo to implant into the uterine lining (endometrium) and develop into a healthy pregnancy. This procedure typically takes place 3 to 5 days after fertilization, depending on whether you and your medical team have chosen a Day 3 (cleavage stage) or Day 5 (blastocyst stage) transfer.
Unlike egg retrieval, which requires anesthesia and involves a surgical procedure, embryo transfer is generally painless and requires no sedation for most patients. It is performed in a clinical setting, similar to a routine pelvic exam, and typically takes only 10 to 15 minutes from start to finish.
Successful embryo transfer depends heavily on the timing of the procedure in relation to the maturation of the uterine lining. This optimal period is known as the “window of implantation”—a limited timeframe (usually 12–24 hours) when the endometrium is most receptive to an implanting embryo. Your fertility clinic will use blood tests (measuring estrogen and progesterone) and ultrasound monitoring to pinpoint this window with precision.
For patients undergoing a frozen embryo transfer (FET), the preparation phase typically begins with cycle day 2 or 3. Estrogen supplements (oral, injectable, or transdermal) are prescribed to build the uterine lining to an optimal thickness—usually at least 7–8 mm. Once the lining has reached the appropriate thickness and hormonal levels are confirmed, progesterone supplementation begins. Embryo transfer is then scheduled for a specific number of hours after the first progesterone dose (commonly 120 to 144 hours for a blastocyst transfer).
In the days leading up to your transfer, you will be taking a regimen of medications designed to optimize the uterine environment. These commonly include:
It is critical to follow your clinic’s medication schedule with absolute precision. Missing even a single dose of progesterone can alter the hormonal environment and compromise the chances of successful implantation.
One unique aspect of embryo transfer preparation is the requirement to have a moderately full bladder. A filled bladder serves two important purposes: it straightens the uterine angle, making the catheter path more direct, and it provides an acoustic window for abdominal ultrasound, allowing the physician to visualize the catheter and guide embryo placement with precision. Your clinic will provide specific instructions—typically to drink 16–20 ounces of water 45–60 minutes before the procedure.

On the morning of your transfer, the embryology team will assess the developed embryos one final time. If you have opted for preimplantation genetic testing (PGT-A or PGT-M), only chromosomally normal (euploid) embryos will be considered. The embryologist will select the embryo(s) with the highest morphological grade—evaluating factors such as cell symmetry, fragmentation rate, and expansion (for blastocysts).
You may have the opportunity to view your embryo on a monitor before the transfer. Many clinics also offer embryo photos or videos as a keepsake.
Plan to arrive at the clinic 30–45 minutes before your scheduled transfer time. You will check in at the front desk, complete any necessary paperwork, and change into a gown. Some clinics provide a private waiting area for transfer patients, often with calming amenities such as dimmed lighting or soothing music.
Embryo transfer is typically performed in a procedure room that resembles a cross between an exam room and a miniature operating theater. An ultrasound machine is positioned at the foot of the bed. The embryologist and the physician work together as a coordinated team—the embryologist loads the embryo(s) into the catheter in a separate laboratory area, while the physician prepares the patient.
You will lie on the exam table with your feet in stirrups, similar to a Pap smear. The physician will insert a sterile speculum to visualize the cervix. The cervix is then gently cleaned with a sterile solution (such as saline or culture medium) to remove any mucus that could block the catheter.
A thin, soft catheter (the “transfer catheter”) is then carefully guided through the cervical canal and into the uterine cavity. In some cases, a tenaculum (a small clamp) may be used to stabilize the cervix if it is difficult to navigate—but this is not always necessary.
With the catheter in place, the physician uses abdominal ultrasound to visualize the catheter tip within the uterus. The embryologist enters the room and hands the loaded catheter to the physician. The physician then slowly advances the catheter to the predetermined location (usually the mid-portion of the uterine cavity, 1–2 cm from the uterine fundus) and depresses the syringe plunger, releasing the embryo(s) in a small volume of culture medium.
A distinctive “flash” or “bubble” may be visible on the ultrasound screen as the fluid is released—this confirms correct placement. The catheter is then slowly withdrawn.
After withdrawal, the catheter is immediately handed back to the embryologist, who examines it under a microscope to confirm that all embryos were successfully expelled. If any embryo remains in the catheter (a “retained embryo”), a second attempt at placement may be made, though this is relatively uncommon with experienced practitioners.
After the procedure, you will be asked to rest on the exam table for 15–30 minutes. Some clinics recommend lying quietly; others encourage gentle movement (such as wiggling your toes) to promote blood circulation. There is no scientific consensus on whether bed rest improves outcomes—most clinics now recommend a brief rest followed by normal, light activity.

The first few days after embryo transfer are a time of physical recovery and emotional anticipation. You may experience mild cramping, light spotting, or vaginal discharge from the medications. These symptoms are normal. Continue taking all prescribed medications exactly as directed—do not stop progesterone or estrogen until instructed by your physician, even if you suspect your period is starting.
Activity recommendations vary by clinic, but most advise avoiding:
Implantation typically begins 1–5 days after a blastocyst transfer (or 3–7 days after a Day 3 transfer). During this time, the embryo hatches from its protective shell (zona pellucida), attaches to the endometrial lining, and begins to invade the uterine tissue. You may notice light implantation bleeding (pink or brown spotting)—this is a positive sign and affects approximately 30% of pregnant patients.
Some patients choose to track symptoms during this period, but it is important to remember that many women experience no symptoms at all and still achieve a successful pregnancy. Progesterone supplements can also cause symptoms (such as breast tenderness, bloating, and mood changes) that mimic early pregnancy, making symptom-spotting unreliable.
The “two-week wait” (TWW) is widely considered the most emotionally challenging part of the IVF journey. The only definitive way to confirm pregnancy after embryo transfer is a beta hCG blood test, typically scheduled 9–14 days after transfer (most commonly day 10–12 for blastocyst transfers).
Home pregnancy tests are not recommended during this period for two reasons: (1) the sensitivity of over-the-counter tests varies, and a false negative can cause unnecessary distress; and (2) trace amounts of hCG from the trigger shot (if used) or from the embryo culture medium can produce a false positive. Wait for the official beta.
Embryo transfer success rates depend on multiple factors, including maternal age, embryo quality, the expertise of the clinic, and underlying fertility diagnoses. According to the latest data from the international surrogacy and IVF literature, the average implantation rate per blastocyst transfer in women under 35 is approximately 50–60%. For women aged 35–37, the rate drops to 40–50%; for women over 40, it may be below 20%.
Factors that improve success rates include:
For the vast majority of patients, embryo transfer is not painful. Some women describe mild discomfort from the speculum or a sensation of pressure during catheter insertion, but the procedure does not require anesthesia. If you experience significant anxiety, discuss mild sedation options with your clinic in advance.
The number of embryos transferred is a carefully considered decision that balances the desire for a high pregnancy rate against the risks of multiple pregnancy (twins, triplets). In most countries, single embryo transfer (SET) is now the standard recommendation for patients under 35 with a high-quality blastocyst, due to the well-documented risks of preterm birth and maternal complications associated with twin pregnancies. Your physician will discuss the optimal number based on your age, embryo quality, and personal preferences.
In some cases, the transfer may be cancelled before the procedure. Common reasons include: inadequate endometrial thickness, a sudden hormonal imbalance, or the absence of viable embryos. If this happens, your cycle may be converted to a “freeze-all” approach (if embryos are present), or you may be advised to rest and try again in a future cycle. While disappointing, a cancelled transfer protects you from a cycle with a very low chance of success.
Yes, most patients can return to work the day after their transfer, provided their job does not involve heavy physical labor. There is no evidence that normal daily activity reduces implantation rates. In fact, prolonged bed rest is no longer recommended and may actually increase stress and reduce blood flow to the uterus.
The beta hCG blood test is the gold standard for confirming pregnancy after embryo transfer. This test is typically performed 10–12 days after a blastocyst transfer. If the initial beta is positive, a second test is usually scheduled 48–72 hours later to confirm that hCG levels are rising appropriately (a doubling time of approximately 48 hours in early pregnancy).
The embryo transfer phase is emotionally intense. It is normal to feel a mix of hope, anxiety, and vulnerability. Consider the following strategies to support your mental health during this time:
Many patients find it helpful to schedule a counseling session or join a support group (in-person or online) specifically for IVF patients. Organizations such as RESOLVE (in the United States) and similar fertility advocacy groups worldwide offer valuable resources and community connections.
Embryo transfer represents a remarkable convergence of science, skill, and hope. By understanding each step of the process—from medication preparation to the two-week wait—you can approach your transfer with greater confidence and clarity. While the outcome of any individual transfer cannot be guaranteed, advances in embryology, ultrasound guidance, and laboratory techniques have made modern embryo transfer safer and more effective than ever before.
Remember that you are not alone on this journey. Your fertility clinic’s team—physicians, nurses, embryologists, and mental health professionals—are all committed to supporting you. Take each day as it comes, trust the process, and be gentle with yourself as you navigate this profound chapter toward building your family.
For more information about TCC Surrogacy and our comprehensive IVF process guidance for international parents, please explore our additional resources or contact our team directly. We are here to help you achieve your dream of parenthood—every step of the way.
Georgia Surrogacy Services,Legal IVF Hospital,Global Fertility Agency